ORTHO
BULLETS
Free CME
Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 211288

Bone Growth Factors Peroxisome proliferator-activated receptor gamma (PPAR-gamma or PPARG) Clinical and research applications QID: 211288 (SBQ18BS.17)
In scope icon L 4 E
QID 211288 (Type "211288" in App Search)
A 65-year-old patient with a history of type 2 diabetes presents to clinic after sustaining a distal radius fracture secondary to a ground-level fall. Upon evaluation of the patient’s risk factors for osteoporosis, you note that they are taking a thiazolidinedione as part of their treatment regimen for diabetes. What is the mechanism of action of this medication in relation to bone mineral density (BMD)?
Type in at least one full word to see suggestions list